Then, mutations affecting DNA methylation (TET-2 and DNMT3A), histone modification (ASXL1), or splicing factors (SF3B1, SRSF2, U2AF1) have been associated with increased inflammation in patients with CHIP or MDS. The gene discussed is TET2; the disease is myelodysplastic syndrome.